Cystic lymphangioma of the breast.
L de Guerké, M Baron, P Dessogne… - Breast …, 2005 - search.ebscohost.com
Presents a case report of a pregnant woman with a sudden inflammatory left breast lesion.
Revelation of an inflammatory nontender mass in the upper outer section of the left breast; …
Revelation of an inflammatory nontender mass in the upper outer section of the left breast; …
[HTML][HTML] The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery …
…, A Dugas, JF Tremblay, S Fortin, L De Guerké… - Current …, 2022 - mdpi.com
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is a
treatment option for peritoneal metastases (PM) but is associated with significant …
treatment option for peritoneal metastases (PM) but is associated with significant …
Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions
…, CA Filion, MH Auclair, J Noujaim, L de Guerké… - Annals of Allergy …, 2023 - Elsevier
Background Cytokine-release reactions (CRR) induced by platinum-based chemotherapy,
manifesting with fever, chills, and rigors, are poorly understood and not easily prevented by …
manifesting with fever, chills, and rigors, are poorly understood and not easily prevented by …
[HTML][HTML] Esophagitis as a complication of the combination of lenvatinib and pembrolizumab for advanced endometrial cancer: A case report
…, MH Auclair, S Fortin, J Berdugo, L de Guerké - Gynecologic Oncology …, 2023 - Elsevier
Background Pembrolizumab is a monoclonal antibody targeting the programmed cell death
protein 1 (PD-1). It is used in the management and treatment of various oncologic …
protein 1 (PD-1). It is used in the management and treatment of various oncologic …
EPV181/# 221 Carboplatin-based hyperthermic intraperitoneal chemotherapy for managing advanced primary and recurrent ovarian carcinoma–a single-center …
C Brault, A Brind'Amour, L De Guerké, MH Auclair… - 2021 - ijgc.bmj.com
Objectives Studies have highlighted the benefits of combining cytoreductive surgery with
HIPEC to improve survival in primary and recurrent EOC. However, data regarding the use …
HIPEC to improve survival in primary and recurrent EOC. However, data regarding the use …